Signaling pathways and advances in targeted therapy for adenomyosis
Frontiers in Cell and Developmental Biology · 06.11.2025 · 13
DOI: 10.3389/fcell.2025.1685525 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 06.11.2025. Verfasst von Yue Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adenomyosis is a common estrogen-dependent disease, characterized by the invasion of endometrial glands and stroma into the myometrium. It often results in dysmenorrhea, menorrhagia, and infertility, significantly impacting patients’ quality of life. Currently, the etiology and pathogenesis of adenomyosis remain unclear, and existing treatments have limitations. Therefore, further research on the mechanism and treatment of adenomyosis is urgently needed. Studies indicate that adenomyosis involves dysregulation of multiple signaling pathways, including VEGF, Wnt, PI3K, MAPK, NF-κB, cGAS-STING, TGF-β, Hedgehog, and Hippo pathways, which regulate processes such as estrogen and progesterone imbalance, angiogenesis, proliferation and invasion, and the processes of inflammation and fibrosis. This review summarizes the relevant signaling pathways involved in adenomyosis and discusses recent progress in targeted pathway therapies. Additionally, emerging therapeutic strategies such as multi-target combination therapy, epigenetic regulation, and natural products are emphasized as viable avenues for adenomyosis treatment in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
- Department of Gynecology, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.
- Gansu Health Vocational College, Lanzhou, China.
Zitieren
APA
Li, Y., Zhang, H., Ding, Y., Zhao, Y., Li, Y., & Qin, T. (2025). Signaling pathways and advances in targeted therapy for adenomyosis. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1685525
Vancouver
Li Y, Zhang H, Ding Y, Zhao Y, Li Y, Qin T. Signaling pathways and advances in targeted therapy for adenomyosis. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1685525
BibTeX
@article{Li2025,
author = {Li, Yue and Zhang, Hongyu and Ding, Yaoyao and Zhao, Yiling and Li, Yufeng and Qin, Tiansheng},
title = {Signaling pathways and advances in targeted therapy for adenomyosis},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1685525}
}
EUVIMED